ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date

Tuesday, November 10, 2015

9:00AM-11:00AM
Abstract Number: 2299
Association Between Catechol-O-Methyl Transferase Gene Polymorphisms and Fibromyalgia in a Korean Population: A Case-Control Study
Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II
9:00AM-11:00AM
Abstract Number: 2475
Association Between Fibromyalgia and Suicidal Risk: A Systematic Review and Meta-Analysis
Psychology/Social Sciences (ARHP)
9:00AM-11:00AM
Abstract Number: 2261
Association Between Musculoskeletal Pain, Fat Mass and Fat Free Mass: Results from a Population-Based Study
Epidemiology and Public Health Poster III (ACR): Gout and Non-Inflammatory Musculoskeletal Conditions
9:00AM-11:00AM
Abstract Number: 2516
Association Between Primary Sjögren’s Syndrome and Pregnancy Outcome: A Systematic Review and Meta-Analysis
Reproductive Issues in Rheumatic Disorders: Basic and Clinical Aspects Poster Session
9:00AM-11:00AM
Abstract Number: 3047
Association Between Red Blood Cell Distribution Width and Disease Activity in Behcet’s Disease
Vasculitis Poster III
9:00AM-11:00AM
Abstract Number: 2400
Association Between Serum Urate and Osteoarthritis Progression in a Non-Obese Cohort
Osteoarthritis - Clinical Aspects Poster II: Biomarkers, Biomechanics and Health Services Research
9:00AM-11:00AM
Abstract Number: 2785
Association of Anti-Glutamate Receptor Subunit NR2 Antibody and Psychiatric Disorder in Patients with Primary Sjögren Syndrome
Sjögren's Syndrome: Translational Insights into Sjögren's Syndrome
9:00AM-11:00AM
Abstract Number: 2947
Association of Anti-NR2 and U1RNP Antibodies with Neurotoxic Inflammatory Mediators in Cerebrospinal Fluid from Patients with Neuropsychiatric Systemic Lupus Erythematosus
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session III
9:00AM-11:00AM
Abstract Number: 2633
Association of Medication Beliefs, Self-Efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis
Rheumatoid Arthritis - Clinical Aspects Poster Session III
9:00AM-11:00AM
Abstract Number: 2589
Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis
Rheumatoid Arthritis - Clinical Aspects Poster Session III
9:00AM-11:00AM
Abstract Number: 2634
Associations Between Health Literacy, Ethnicity, Communication Quality and Beliefs about Medicines in Rheumatoid Arthritis
Rheumatoid Arthritis - Clinical Aspects Poster Session III
9:00AM-11:00AM
Abstract Number: 2818
Associations of IL23R, BMP6 and PTGS1 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis
Spondylarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology Poster II
9:00AM-11:00AM
Abstract Number: 2359
Atorvastatin-Induced Autoimmune Myopathy: An Emerging Dominant Entity in Patients with Autoimmune Myopathy Presenting with a Pure Polymyositis Phenotype
Muscle Biology, Myositis and Myopathies Poster II: Autoantibodies and Treatments in Inflammatory Myopathies
9:00AM-11:00AM
Abstract Number: 2824
Autoantibodies Against CD74 – a New Diagnostic Marker for Spondyloarthritis (SpA)
Spondylarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology Poster II
9:00AM-11:00AM
Abstract Number: 2595
Autoantibodies to Citrullinated Fibrinogen, Anti-CCP2 and Anti-MCV Antibodies in Early Rheumatoid Arthritis Patients with Rapid Radiographic Progression at 1-Year
Rheumatoid Arthritis - Clinical Aspects Poster Session III
  • «Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 72
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology